Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
Authors:
Open Access
- 30 April 2020
- journal article
- editorial
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 14 (2) , 100-102
Abstract
The world is in the midst of the coronavirus disease 2019 (COVID-19) pandemic. Interleukin 6 (IL-6) inhibitor (tocilizumab) had been suggested for the treatment of acute respiratory distress syndrome (ARDS) patients based on the concept of "cytokine storm" in COVID-19. However, we still lack reliable studies to verify "cytokine storm" in COVID-19 pneumonia. Furthermore, IL-6 inhibitor has potential hazards of inducing infectious diseases. The efficacy of IL-6 monoclonal antibody-directed therapy remains to be fully evaluated.Keywords
This publication has 17 references indexed in Scilit:
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, ChinaClinical Infectious Diseases, 2020
- Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcomemedRxiv, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- The Role of Interleukin 6 During Viral InfectionsFrontiers in Microbiology, 2019
- Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed TherapiesAnnual Review of Medicine, 2015
- Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatmentJournal of General Virology, 2013
- Avian Influenza A (H5N1) Infection in HumansNew England Journal of Medicine, 2005